Communications

Advertising Communications Graphic Design Internet Marketing Media Publishing SEO
News Release Digital Asset Direct

NOA Lithium Strikes Critical Water: A Game-Changing Discovery for Rio Grande Project

Global Markets News

In the parched landscapes of Argentina's Lithium Triangle, water is as valuable as the lithium itself. NOA Lithium Brines Inc. (TSXV: NOAL) (OTCPK: NLIBF) has just announced a discovery that could dramatically accelerate the development timeline of its flagship Rio Grande Project—fresh water. The company revealed today that it has successfully located an on-site fresh water source within its 100%-owned Rio Grande Project boundaries, marking a pivotal milestone in the project's advancement toward production. Why This Water Discovery Matters For lithium brine projects, access to industrial water is a make-or-break factor. In the arid regions where lithium salars are typically found, securing water rights and sources can be challenging, expensive, and time-consuming. By discovering this resource on its own property, NOA has eliminated a significant hurdle in the development pathway. "This marks another significant milestone in the advancement of the Rio Grande Project," stated Gabriel Rubacha, NOA's Chief Executive Officer. "Not only have we discovered a fresh water source on-site and within our properties, but its location aligns perfectly with the area of highest lithium concentration and our preliminary assessment for locating a production facility and evaporation ponds." The strategic positioning of this water well, drilled to a depth of 190 meters in the northern section of the project, couldn't be more advantageous. It's situated close to the areas where NOA has identified the highest concentration of lithium and porosity to date—precisely where the company envisions developing future production facilities and evaporation ponds. A Series of Strategic Wins This water discovery adds to NOA's impressive streak of achievements over the past year. The company has methodically checked off critical boxes in its development roadmap: The water well represents one of three fresh water targets identified at Rio Grande, suggesting further potential for expanded water resources as development continues. Positioned in the Heart of the Lithium Triangle NOA's strategic position in Argentina's Lithium Triangle gives it proximity to some of the world's highest-grade, lowest-cost lithium operations. The company has assembled one of the largest lithium brine claim portfolios in the region not owned by a producing company, with over 140,000 hectares across three prospective salars: Rio Grande, Arizaro, and Salinas Grandes. This vast land package in Salta Province—widely recognized as one of Argentina's most mining-friendly jurisdictions—positions NOA alongside industry leaders like Arcadium, Lithium Argentina, Ganfeng, and Rio Tinto. Looking Forward: Accelerating Development With the PEA expected in Q3 2025, NOA is rapidly advancing toward a comprehensive economic evaluation of the Rio Grande Project. The current design contemplates an initial production capacity of approximately 20,000 metric tonnes per year of lithium carbonate equivalent, with scalability to double that capacity through modular expansion. The water discovery adds tangible value to this economic assessment by potentially reducing both capital and operating costs associated with water procurement and transport. As global lithium demand continues to surge, driven by electric vehicle adoption and energy storage requirements, NOA's steady advancement of its Rio Grande Project positions it as an emerging player in the lithium supply chain at precisely the right time. For investors watching the lithium space, NOA's methodical derisking of its flagship project and continued achievement of development milestones make it a compelling story to follow as it progresses toward its goal of becoming Argentina's next major lithium producer. ‎ Recent News Highlights from NOA Lithium: NOA Lithium Discovers Fresh Water at Rio Grande Project NOA Engages Hatch To Lead Preliminary Economic Assessment For Its Rio Grande Project NOA Lithium Advances Towards 2025 Water Exploration at Rio Grande Project Read more about other lithium stocks: NASDAQ: PWM | OTC: LTMCF | NYSE: ALB | NYSE: LAC | OTCQB:NRVTF * Legal Disclaimer & Disclosure - Paid Advertisement: This content is a paid advertisement. Wall Street Wire has received compensation from NOA Lithium Brines Inc. for promotional media services provided on an ongoing subscription basis. This content is for informational purposes only and does not constitute financial advice. Wall Street Wire is not a broker-dealer or investment adviser. Full compensation details and information regarding the operator of Wall Street Wire are available here redditwire.com/terms or in NOA's disclosure's THIS ARTICLE CONTAINS SPONSORED CONTENT PUBLISHED ON BEHALF OF NOA LITHIUM BRINES Contact Details ‎ media.globalmarkets@gmail.com

June 24, 2025 09:18 AM Eastern Daylight Time

News Release

DarioHealth's Platform Solves GLP-1's Biggest Problem, New Research Shows, While Trading at 1% of Hinge Health's $3 Billion Valuation

Global Markets News

DarioHealth Corp. (NASDAQ: DRIO), a digital health innovator in the chronic condition management space, just unveiled significant research findings at the American Diabetes Association Scientific Sessions that could dramatically improve its position in the $100 billion weight loss market. The company's studies demonstrate sustainable outcomes for GLP-1 users even after discontinuing medication - addressing a critical challenge in the industry. The latest findings revealed dramatic improvements in GLP-1 users, with average blood glucose levels dropping from an estimated A1c of 9.0% to 6.7%. Most importantly, users who discontinued GLP-1 medication maintained stable outcomes with no significant weight or glucose rebound for at least six months, according to the company's research. The company's platform leverages artificial intelligence to deliver personalized interventions, with its AI predictive models achieving 89% accuracy in forecasting future glucose levels. These capabilities position DarioHealth to support the growing demand for effective GLP-1 management solutions. Valuation Gap Creates Opportunity With DRIO shares currently trading around $0.69 and a market cap of approximately $30 million, the company appears dramatically undervalued compared to digital health peers. Hinge Health (NYSE: HNGE), which focuses primarily on musculoskeletal care, recently completed its IPO in May 2025 and now trades with a market cap of over $3 billion. This valuation disparity highlights the potential upside for DarioHealth investors. Unlike Hinge Health's focus on musculoskeletal care, DarioHealth offers a multi-condition platform addressing diabetes, hypertension, weight management, and behavioral health. This broader approach provides more comprehensive value to health plans and employers seeking to consolidate digital health vendors. DarioHealth has made strategic moves to strengthen its market position: The company expanded its GLP-1 capabilities through a partnership with MediOrbis, adding prescribing capabilities to enhance its weight management solution It's targeting both employer markets and direct-to-consumer channels The company has built its client base to 97 organizations with a reported 90%+ renewal rate The latest research validates DarioHealth's approach to sustainable weight management. With 44% of large employers now covering obesity drugs according to a Mercer survey, the demand for supportive digital health tools continues to grow. The Financial Picture DarioHealth has been making progress toward improved financial performance. In Q1 2025, the company reported revenue of $6.75 million, a 17% year-over-year increase, with gross margins of 57.5% (70.5% on a non-GAAP basis). Operating expenses decreased 35% compared to the previous year, as the company works toward its stated goal of operational cash flow breakeven by the end of 2025. The Bottom Line As GLP-1 medications continue to reshape weight management approaches, DarioHealth's platform offers a solution to maintain outcomes beyond medication use. The company's comprehensive condition management approach contrasts with more narrowly focused digital health providers like Hinge Health. For investors interested in the digital health sector, DarioHealth may represent an opportunity at current price levels, though it carries the execution risks typical of smaller healthcare technology companies. The significant valuation gap between DarioHealth's $30 million market cap and Hinge Health's $3 billion valuation highlights the potential upside if the company continues to execute on its strategy and build on its latest research findings. ‎ Recent News from Dario: Dario Unveils Groundbreaking GLP-1 and AI-Personalization Digital Health Findings DarioHealth Reports First Quarter 2025 Financial and Operating Results Dario's Digital Health Solution Demonstrates Effectiveness in New Research Examining Flu Vaccination Awareness in High-Risk Populations DarioHealth to Report First Quarter 2025 Results on Wednesday, May 14, 2025 DarioHealth Closes Strategic Refinancing of Existing Debt Facility of up to $50 Million to Provide Additional Operational Flexibility and Support Growth Initiatives ‎ Important Legal Disclaimer & Disclosur e - Paid Advertisement: This content is a paid advertisement. Wall Street Wire has received compensation from DarioHealth Corp. for promotional media services provided on an ongoing subscription basis. This content is for informational purposes only and does not constitute financial advice. Wall Street Wire is not a broker-dealer or investment adviser. Full compensation details and information regarding the operator of Wall Street Wire are available redditwire.com/terms. Contact Details ‎ media.globalmarkets@gmail.com

June 24, 2025 09:07 AM Eastern Daylight Time

News Release

The $4.1 Trillion Healthcare Revolution: How DarioHealth Could Rewrite the Rules of Chronic Disease Management

Global Markets News

Imagine a world where managing multiple chronic conditions isn’t a nightmare of fragmented care, endless appointments, and mounting medical bills. This isn’t a futuristic fantasy, it’s the vision of DarioHealth Corp. (NASDAQ: DRIO)*, a digital health company that’s quietly building what could be the most comprehensive solution to America’s chronic disease crisis. The numbers are staggering. Chronic diseases consume a mind-boggling 90% of the $4.1 trillion U.S. healthcare budget, according to the CDC. Worse, 42% of Americans juggle multiple chronic conditions, with 12% managing five or more. It’s a system broken beyond repair, or so it seemed. Enter DarioHealth, a digital health innovator that’s reimagining healthcare from the ground up. Unlike traditional point solutions that tackle one condition at a time, this company has developed an AI-powered platform that simultaneously addresses diabetes, hypertension, weight management, musculoskeletal pain, and mental health. The company’s journey is as compelling as its technology. Born from years of user interaction data spanning 150,000 consumers, DarioHealth has built more than just an app, it’s created an intelligent ecosystem that learns and adapts to individual health journeys. Their AI-driven platform isn’t just tracking metrics; it’s predicting and preventing health complications before they escalate. But this isn’t just another tech pipe dream. The company’s approach is delivering real-world results that are turning heads across the healthcare industry. Imagine reducing hyperglycemic events by 58%, cutting anxiety symptoms by 59%, and delivering a 5x return on investment for healthcare payers. These aren’t marketing promises, they’re proven outcomes. The GLP-1 weight loss revolution provides a perfect window into DarioHealth’s strategic brilliance. With the weight loss medication market set to explode to $100 billion by 2030, the company has positioned itself as more than just a support platform. Through a strategic partnership with MediOrbis, they now offer integrated medication prescribing, solving the critical problem that sees 75% of patients discontinuing GLP-1 medications within a year. 2025 has been a breakthrough year. The company has added 14 new clients, bringing their total to 97 organizations. More importantly, over 80% of new contracts now cover multiple health conditions, a clear validation of their holistic approach. Major players like Blue Cross Blue Shield are taking notice, and the company’s client renewal rate sits at an impressive 90%. Financially, the story is equally compelling. First-quarter 2025 revenues hit $6.75 million, a 17% year-over-year growth. But the real magic is happening behind the scenes. The company is deploying AI to streamline operations, with a laser focus on reaching operational cash flow breakeven by the end of 2025 or early 2026. Recent industry comparisons, like the recent IPO of Omada Health (NASDAQ: OMDA) at much higher multiples, highlight the potential undervaluation of DarioHealth’s innovative platform. For investors tired of overhyped tech promises, DarioHealth may offer something different. Trading at around $0.69 with a market cap of ~$30 million, this could be the definition of a hidden gem. The company isn’t just building a product, it’s reimagining how chronic disease management could work in the digital age. Consider the market opportunity. With 129 million Americans suffering from at least one major chronic disease, and healthcare costs continuing to spiral, DarioHealth sits at the intersection of a massive market need and technological innovation. Recent analyst reports have even suggested the stock could reach $3, a potential 335% upside from current levels. This isn’t just another digital health play. This is a potential blueprint for the future of healthcare, personalized, integrated, and powered by intelligent technology. In a world where healthcare complexity continues to grow, DarioHealth represents a beacon of hope, promising not just management, but meaningful transformation of how we approach chronic health. ‎ ‎ Recent News Highlights from Dario DarioHealth Reports First Quarter 2025 Financial and Operating Results Dario's Digital Health Solution Demonstrates Effectiveness in New Research Examining Flu Vaccination Awareness in High-Risk Populations DarioHealth to Report First Quarter 2025 Results on Wednesday, May 14, 2025 DarioHealth Closes Strategic Refinancing of Existing Debt Facility of up to $50 Million to Provide Additional Operational Flexibility and Support Growth Initiatives - * Legal Disclaimer & Disclosure - Paid Advertisement: This content is a paid advertisement. Wall Street Wire has received compensation from DarioHealth Corp. for promotional media services provided on an ongoing subscription basis. This content is for informational purposes only and does not constitute financial advice. Wall Street Wire is not a broker-dealer or investment adviser. Full compensation details and information regarding the operator of Wall Street Wire are available redditwire.com/terms. Contact Details ‎ media.globalmarkets@gmail.com

June 23, 2025 10:54 AM Eastern Daylight Time

Courageous Conservatives PAC to Rep. Pat Curry Ahead of June 6 Hearing: You Can’t Sue Your Way Out of Accountability

Courageous Conservative PAC

The Courageous Conservatives Political Action Committee, dedicated to electing leaders who uphold the values of sovereignty, strength, and principled conservative governance, will argue against a baseless “SLAPP” lawsuit brought by Rep. Pat Curry in court this week. Courageous Conservatives PAC is confident the court will recognize Curry’s attempt to sue critics into silence for what it is: a politically motivated attempt to suppress free speech and silence grassroots conservatives. “This lawsuit isn’t about the law. It’s about power.” said Chris Ekstrom, Chairman of Courageous Conservatives PAC, “Pat Curry is trying to use the courts to muzzle those who dare to hold him accountable and remind him of the promises he made to his constituents. That’s not justice—that’s political retribution.” The Courageous Conservatives PAC has moved to dismiss the suit under the Texas Citizens Participation Act, citing its clear protections of free speech, the right to petition, and freedom of association. The communications in question—texts and Facebook posts—were fully independent and directed solely to the public, urging civic participation on an important issue: the election of the Texas House Speaker. “Our message to Pat Curry’s district and specifically the voters who elected him was straightforward,” Ekstrom added. “’Call Representative Curry and demand he keep his word’. That’s not just legal political messaging; it is how the American Republic was intended to function.” Curry’s lawyers filed a response to the motion last week. “Despite two months to think about it, amazingly, Curry’s lawyers made no attempt to explain why any of their claims have legal merit,” said Jerad Najvar of Chalmers, Adams, Backer & Kaufman LLC. “Our motion explained, point by point, why the PAC’s speech was legal and complied with Texas law. Instead of defending the substance of his frivolous claims, Curry makes the desperate argument that speech on an issue of public concern by a conservative group is somehow ‘commercial speech’ because the PAC paid to distribute it—and therefore not subject to dismissal under the TCPA. Curry’s argument wholly ignores decades of speech law.” “Rep. Curry’s lawsuit is meritless, and frankly, dangerous,” Ekstrom said. “It sets a chilling precedent if public officials can sue private citizens and organizations simply for encouraging civic engagement. We’re not backing down—and neither should any American who believes in the First Amendment.” Courageous Conservatives PAC is also seeking attorney’s fees and sanctions in response to the frivolous and retaliatory suit. “Our commitment to conservative values and political accountability will not be intimidated into silence,” said Ekstrom. “We will continue to defend the rights of the people to speak out and demand integrity from their elected officials—no matter who tries to stop us.” The hearing is scheduled for Friday, June 6, 2025, at 9:00 a.m. The Court is located at 501 Washington Ave., Waco, TX 76701. Interviews with Chris Ekstrom will be available in advance of and following the hearing. About Courageous Conservatives PAC Courageous Conservatives PAC is a grassroots-driven political action committee dedicated to electing principled conservative leaders who will fight for American values, national sovereignty, and an America First agenda. Led by Chairman Chris Ekstrom, the PAC works to ensure that the voices of patriotic Americans are heard — not silenced — locally and nationwide. ### For more information, or to schedule an interview with Chris Ekstrom please contact Dan Rene at 202-329-8357 or dan@danrene.com Contact Details Courageous Conservatives PAC Dan Rene +1 202-329-8359 dan@danrene.com Company Website https://courageouspac.com/

June 02, 2025 03:30 PM Eastern Daylight Time

Inspira Technologies Receives $2 Price Target and Buy Rating: Everything You Need to Know

Global Markets News

Litchfield Hills Research has initiated coverage of Inspira Technologies OXY B.H.N. Ltd. (NASDAQ: IINN)* with a Buy rating and a $2 price target, representing potential upside of over 225% from current trading levels of around $0.61 per share. This bullish outlook comes as the medical technology company continues to critical care technology addressing what the analyst describes as "a medical need without good options." The analyst notes that mechanical ventilators are "WWII technology in desperate need of an upgrade" with reports showing that 30% to 50% of ICU patients don't survive. Unlike mechanical ventilation, Inspira's ART500 technology would enable patients to remain awake during treatment while stabilizing oxygen levels without intubation and coma. What distinguishes Inspira from typical early-stage medical device companies is its proven regulatory execution and early commercial success. The company's first generation technology, the INSPIRA ART100 system, received FDA clearance in May 2024 and is already deployed in leading U.S. hospitals. The excitement around this technology reached a new high in April 2025 when the first successful patient treatment was completed at Westchester Medical Center. The commercial momentum seems to be accelerating. Inspira announced it received payment in the "low hundreds of thousands of dollars" from its U.S. distributor for delivered systems, marking the company's first revenues. CEO Dagi Ben-Noon called this "a transformative milestone for Inspira as we establish our presence in the U.S. medical landscape." The company has now initiated global commercial rollout discussions and expects additional deliveries in the second half of 2025. Central to Inspira's technology platform is the AI-powered HYLA blood sensor, which recently achieved 96% accuracy in clinical studies at Sheba Medical Center, one of the world's top hospitals. The system provides continuous monitoring without requiring blood draws, targeting the blood gas analyzer market projected to reach $5.7 billion by 2030. The analyst identifies massive market opportunities, with the global mechanical ventilators market expected to reach $20.69 billion by 2034. Inspira's flagship INSPIRA ART500 system in development aims to disrupt this market by providing respiratory support through direct blood oxygenation rather than forcing air into damaged lungs. Inspira has established strong intellectual property protection with multiple U.S. patents and novel patent claims protecting its core technologies. The company is executing a strategic approach of securing FDA clearance for individual components before integrating them into comprehensive systems. When comparing Inspira to similar medical device companies, the analyst found the stock trades at significant discounts despite having FDA-cleared technology already treating patients. The $2 price target reflects confidence in the company's ability to capitalize on its early commercial success and expand into the massive mechanical ventilation market. The analyst concludes that Inspira may represents a unique opportunity, combining proven FDA-cleared technology with substantial market opportunity and attractive valuation metrics in the high-growth medical device sector. Recent News from Inspira: Inspira Technologies Initiates Global Commercial Rollout of FDA-Cleared ART100 System INSPIRA ART100 System Approved by Israel's Largest Healthcare Provider for Use in Organ Transplant Patients Inspira Achieves above 99% Gas Exchange Efficiency in VORTX™ Technology In-Vivo Animal Testing * Legal Disclaimer & Disclosure: Nothing in this article constitutes financial or investment advice, nor does it represent an offer to buy or sell securities. This report is published by the Wall Street Wire platform & media network. The operators of Wall Street Wire are not registered brokers, dealers, or investment advisers. This article contains paid promotional content related to Inspira Technologies and was produced as part of their paid subscription to Wall Street Wire, which includes a monthly fee of five thousand US dollars paid in cash via bank transfer in return for promotional content and distribution services. The operators also receive additional fees for non promotional advisory and data services. Inspira Technologies did not necessarily review or approve this content prior to publication. Please review the full disclaimers and compensation disclosures here which include further details: redditwire.com/terms. We are not responsible for third party analyst price targets or market estimates are refer to them based on publicly availble reports. Additional or competing price target may exist and readers are advised to refer to the full report and its respective disclaimers and disclosures. Contact Details Wall Street Wire Editorial Desk media.globalmarkets@gmail.com

June 02, 2025 09:19 AM Eastern Daylight Time

Finding Ferdinand Shatters Sales Projections Following Debut Retail Launch at Credo Beauty

Finding Ferdinand

Finding Ferdinand, the sister-run brand on a mission to elevate your everyday routine with vegan, skin-loving formulas, is shattering sales projections just two months into the brand’s retail debut with Credo Beauty. In March 2025, the clean beauty brand launched online on credobeauty.com and rolled out to 14 Credo Beauty stores nationwide. Finding Ferdinand has far exceeded expectations since launching at Credo Beauty. Within just two months of the retail launch, the brand surpassed sales forecasts by an impressive triple digits. Additionally, Finding Ferdinand’s viral black lip balm was one of the top selling products during the Friends of Credo sale. Credo Beauty’s Senior Color Merchant, Meghan Lim, praised the brand as “Best in Class” for its exceptional launch performance at the retailer. “It’s been incredibly exciting to see Finding Ferdinand on shelves at Credo Beauty — a huge milestone for us. We’re absolutely ecstatic about the success so far, and this is just the beginning. Credo Beauty has been such a thoughtful and supportive partner, truly aligned with our values. Together, we’re keeping the momentum going by creating thoughtful in-store events and developing products and colors we know our customers will use and love,” said Nhu Le, Founder of Finding Ferdinand. Founded in 2015 by Nhu Le and now run alongside her sister, My Le, Finding Ferdinand celebrates its 10-year anniversary this year, marking a decade of innovation in color cosmetics. Nhu and My’s inspiration for the brand came from the incredible women in their family, especially their mother, a two-time cancer survivor whose strength continues to inspire the brand’s deep commitment to clean formulas. Finding Ferdinand products are 100% vegan and cruelty-free, offering proprietary cosmetic formulations that are clean and non-toxic. Finding Ferdinand takes to heart being a part of creating a better future for the world, and is committed to keeping the brand’s production sustainable - from working in small batches to prioritizing recyclable, recycled, or refillable components. For more information, follow the brand on Instagram @findingferdinand and TikTok @findingferdinand. ABOUT FINDING FERDINAND Effortless Beauty for Every Moment. Sister-run beauty brand Finding Ferdinand is here to elevate your everyday routine with vegan, skin-loving formulas that enhance—not hide—what makes you, you. Our clean, high-performance beauty essentials are designed for the way you live: easy to wear, impossible to mess up, and always a perfect fit. We hope you find something you love—and wear it your way, every day. ABOUT CREDO BEAUTY Credo Beauty offers today’s largest clean and sustainably minded beauty assortment in North America, across color, skincare, haircare and fragrance, partnering with over 135 leading brands, such as Westman Atelier, ILIA, OSEA, True Botanicals, Necessaire, and ROZ. Having built the most comprehensive guidelines, “The Credo Clean Standard™", customers can trust that they are purchasing the most effective, innovative products with safer ingredients with an emphasis on sustainable, natural and ethical materials. Trained makeup artists and estheticians (who are continually being educated by Credo Beauty and our brands) offer an exceptional experience both in-store and online. Visit one of the 15 brick-and-mortar store locations or www.credobeauty.com. MEDIA CONTACT Hallie Sawyer hsawyer@ogakidigital.com Contact Details Hallie Sawyer +1 818-388-7338 hsawyer@ogakidigital.com Company Website https://www.findingferdinand.com/

May 21, 2025 04:00 PM Eastern Daylight Time

Roberts & Ryan Inc. Welcomes Rear Admiral Matthew Ott (Ret.) to its Advisory Board

Roberts & Ryan, Inc.

Roberts & Ryan Inc., America’s first Service-Disabled Veteran-Owned Broker Dealer, is pleased to announce that Rear Admiral Matthew Ott (Ret.) has joined the firm’s Advisory Board. Mr. Ott is the founder and CEO of Ott and Associates and the firm On Target Together. He is a retired U.S. Navy Rear Admiral, where he served on amphibious assault ships, destroyers, and aircraft carriers and served across all levels of tactical, operational, and strategic warfare. Accomplished in command overseas and in the U.S., his service ranged from Secretary of Defense Staff, Defense Logistics Agency, U.S. Fleet Forces Command, Naval Supply Systems Command, and culminated in his third return to NAVSUP Weapon Systems Support, leading 2,500 team members across three sites, providing global supply chain management functions for 3,900+ aircraft and 300 ships, submarines, and nuclear reactors for the Navy, Marine Corps, and 80 global partners. A decorated 32-year career officer, Ott is a recognized authority on Supply Chain Management, Complex Systems Architecture, bridging Industry and Government, executing Humanitarian and Disaster Response, and creating tough, winning teams. Ott is best known for enhancing the Navy Sustainment System Supply Architecture as its key material director in the 41B strategic scale design of Navy-wide supply chains to run more effectively and affordably. The complex launches covered aviation, maritime, shipyard, maintenance repair and overhaul, nuclear, ordnance and subsistence markets. A Human Centered Design expert, he creates value using real-time visualization and horizontally integrates complex systems. His leadership, coaching, process discipline and refinement allow stakeholders to win in high stakes environments. His teams are creative, action-oriented, accountable, and focused on leveraging untapped potential to unlock value. Ott received a B.A. in Economics and Business from the Virginia Military Institute. He holds an MBA from the University of North Carolina at Chapel Hill with concentrations in Supply Chain Management and E-business and Digital Commerce. He is a distinguished graduate of the National Defense University’s Industrial College of the Armed Forces (ICAF), where he earned an M.S. in National Security and Resource Strategy. Ott is also Vice President, Partnerships and Alliances for Throughline, an Enterprise Strategy and Design firm where he will continue to bring his military ethos to the commercial world. He speaks about lessons learned, applicability of cross-functional approaches, and applies frameworks to complex problems in the defense, commercial, start-up, small business, and NGO spaces. He is available to serve C-Suite advisory level and teams to be On Target Together. For more on his U.S. Navy Background, please visit the U.S. Navy Website. About Roberts and Ryan, Inc. Roberts & Ryan, Inc. is a Service-Disabled Veteran Owned (SDVO) broker-dealer with execution capabilities in the capital markets, equities, and fixed-income trading. The firm was founded in 1987 by a United States Marine Corps Vietnam combat veteran and Purple Heart recipient. With over $2.38 million in committed donations, Roberts & Ryan is active in donating to charitable foundations that make significant positive impacts in the lives of Veterans and their families, focusing primarily on general wellness, mental health, and career transition. To learn more about Roberts & Ryan, please visit www.roberts-ryan.com. Securities are offered by Roberts & Ryan Inc., member FINRA | SIPC | MSRB | NYSE | NASDAQ. Contact Details Michael C. Del Priore +1 646-859-4061 mdelpriore@roberts-ryan.com Company Website https://www.roberts-ryan.com

May 12, 2025 09:00 AM Eastern Daylight Time

Image

Vocatus Wins Best Marketing or PR Campaign Honor at the 12th Annual Family Wealth Report Awards

Vocatus

Vocatus, a leading communications and marketing firm serving the wealth management industry, announced that it has won the Family Wealth Report Award 2025 for the Best Marketing or PR Campaign. The honor came at the 12 th annual awards ceremony, held on May 8 at the Mandarin Oriental Hotel in New York. The award recognizes the firm’s work on behalf of Callan Family Office, a registered investment advisor serving ultra-high-net-worth families, family offices, foundations and endowments. “I could not be prouder of my entire team for their creativity and ingenuity,” said Vocatus Chief Executive Officer Ray Hennessey. “As a young firm, we are honored to receive this validation from our peers and look forward to continuing to serve the wealth management industry through holistic public relations and marketing support.” The annual Family Wealth Report Awards recognizes the most innovative and exceptional firms, teams and individuals serving the family office, family wealth and trusted advisor communities in North America. "Every category winner and highly commended firm has been subjected to rigorous and independent judging process and be rightly proud of the success they have achieved this year,” said Stephen Harris, ClearView Financial Media’s CEO, and publisher of Family Wealth Report. "We have seen a marked increase in entrants and interest in all our global awards programs and Family Wealth Report is no exception.” Founded in 2022, Vocatus serves dozens of clients, from startups to some of the most established names in the financial services industry. Last year, Vocatus was named a finalist in several well-known wealth management awards, including the WealthManagement.com Industry Awards and ThinkAdvisor Luminaries. About Vocatus Vocatus is a leading communications, marketing and public relations firm, serving the financial services industry. With specialists across media and journalism, Vocatus provides high-level support to individuals and businesses, including wealth management firms, asset managers, fintech companies and business service providers. Contact Details For Vocatus Christina Diabo cdiabo@vocatusllc.com

May 09, 2025 12:17 PM Eastern Daylight Time

Roberts & Ryan Earns Prestigious VETS Indexes 5-Star Employer Award for 2025

Roberts & Ryan, Inc.

Roberts & Ryan, Inc., a Service-Disabled Veteran-Owned broker-dealer, is honored to receive the 2025 VETS Indexes 5-Star Employer Award — one of the program’s highest distinctions. This award celebrates the firm’s strong and ongoing dedication to hiring, developing, and supporting veterans, military spouses, and members of the National Guard and Reserves. The VETS Indexes 5-Star Employer distinction is reserved for organizations that demonstrate a sustained and comprehensive approach to veteran employment, retention, and support. Roberts & Ryan joins a select group of top-performing employers nationwide that serve as role models for veteran-focused workforce development. “Roberts & Ryan has demonstrated exceptional support for veterans and the military-connected community, earning the organization one of the most prestigious awards possible in the VETS Indexes Employer Awards program,” said George Altman, president of VETS Indexes. “Roberts & Ryan is among the very best veteran employers, and its program can serve as a model for others.” Roberts & Ryan’s recognition highlights the firm’s ongoing efforts to support service members transitioning to civilian careers. As a veteran-founded company, Roberts & Ryan understands the unique strengths and experiences veterans bring to the workforce and actively integrates that perspective into its hiring practices, workplace culture, and community outreach. “As a Service-Disabled Veteran-Owned Business, supporting the military-connected community is part of our DNA,” said Edward D’Alessandro, CEO at Roberts & Ryan. “This award reflects our deep commitment to honoring those who serve and not just through employment, but through opportunity, growth, and lasting impact.” The VETS Indexes 5-star Employer award was granted on April 11, 2025 Recipients of the VETS Indexes Employer Awards are selected based on their responses to VETS Indexes’ groundbreaking survey, which examines the most important veteran employment metrics via a granular, objective, and data-focused questionnaire. There was no compensation paid or received for consideration of the award. To view the full list of 2025 VETS Indexes Employer Awards recipients, visit: https://vetsindexes.com/award-results-2025 About Roberts and Ryan, Inc. Roberts & Ryan, Inc. is a Service-Disabled Veteran Owned (SDVO) broker-dealer with execution capabilities in the capital markets, equities, and fixed-income trading. The firm was founded in 1987 by a United States Marine Corps Vietnam combat veteran and Purple Heart recipient. With over $2.38 million in committed donations, Roberts & Ryan is active in donating to charitable foundations that make significant positive impacts in the lives of Veterans and their families, focusing primarily on general wellness, mental health, and career transition. To learn more about Roberts & Ryan, please visit www.roberts-ryan.com. Securities are offered by Roberts & Ryan Inc., member FINRA | SIPC | MSRB | NYSE | NASDAQ. Contact Details Michael C. Del Priore +1 646-859-4061 mdelpriore@roberts-ryan.com Company Website https://www.roberts-ryan.com

April 29, 2025 09:10 AM Eastern Daylight Time

1 2 3 4 5 ... 85

Back